Akiyoshi Ohtake

发表

Effects of intravenously and orally administered solifenacin succinate (YM905) on carbachol-induced intravesical pressure elevation and salivary secretion in mice.

M. Sasamata, Shuichi Sato, Y. Noguchi, 2007, Biological & pharmaceutical bulletin.

Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test.

M. Sasamata, Y. Noguchi, A. Ohtake, 2007, European journal of pharmacology.

Synergistic Effect by Co‐Administration of Tamsulosin and Solifenacin on Bladder Activity in Rats

Hideyuki Yamamoto, M. Sasamata, K. Sugaya, 2012, Lower urinary tract symptoms.

The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes.

M. Sasamata, Shuichi Sato, A. Ohtake, 2010, Journal of pharmacological sciences.

Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.

M. Sasamata, Shuichi Sato, Y. Noguchi, 2007, Biological & pharmaceutical bulletin.

In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract

A. Fujimori, K. Sudoh, M. Sasamata, 2008 .

Participation of endogenous endothelin and ETA receptor in premicturition contractions in rats with bladder outlet obstruction

M. Sasamata, Shuichi Sato, Y. Noguchi, 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological Characterization of YM598, a Selective Endothelin-A Receptor Antagonist

A. Fujimori, K. Sudoh, M. Sasamata, 2004, Journal of cardiovascular pharmacology.

In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats

M. Sasamata, Shuichi Sato, A. Ohtake, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

Potentiation of Muscarinic M3 Receptor Activation through a New Allosteric Site with a Novel Positive Allosteric Modulator ASP8302

T. Ishigami, N. Yoshimura, H. Takamatsu, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, European journal of pharmacology.

Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.

H. Takamatsu, A. Ohtake, Keiko Tanaka-Amino, 2021, European journal of pharmacology.

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.

M. Sasamata, Shuichi Sato, Seiji Kobayashi, 2004, European journal of pharmacology.

Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation

Shuichi Sato, Y. Noguchi, K. Ueshima, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.

M. Sasamata, Shuichi Sato, H. Uemura, 2011, The Journal of urology.

Effect of tamsulosin on bladder microcirculation in a rat ischemia-reperfusion model, evaluated by pencil lens charge-coupled device microscopy system.

M. Sasamata, Masashi Kato, Y. Funahashi, 2010, Urology.

Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction.

M. Sasamata, Shuichi Sato, H. Uemura, 2008, Urology.

In vivo studies on the effects of α1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits

M. Sasamata, M. Michel, Y. Noguchi, 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.